Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 1.264B
March 31, 2026 1.172B
December 31, 2025 1.186B
September 30, 2025 1.257B
June 30, 2025 1.205B
March 31, 2025 1.305B
December 31, 2024 982.84M
September 30, 2024 580.09M
June 30, 2024 416.00M
March 31, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021 1.375B
December 31, 2020 1.277B
September 30, 2020 1.216B
June 30, 2020 1.071B
Date Value
March 31, 2020 948.30M
December 31, 2019 641.78M
September 30, 2019 767.72M
June 30, 2019 738.25M
March 31, 2019 569.22M
December 31, 2018 873.59M
September 30, 2018 805.50M
June 30, 2018 843.01M
March 31, 2018 908.42M
December 31, 2017 949.43M
September 30, 2017 828.31M
June 30, 2017 835.94M
March 31, 2017 702.67M
December 31, 2016 612.03M
September 30, 2016 752.22M
June 30, 2016 728.67M
March 31, 2016 855.18M
December 31, 2015 829.23M
September 30, 2015 901.01M
June 30, 2015 1.036B
March 31, 2015 1.166B
December 31, 2014 1.298B
September 30, 2014 1.194B
June 30, 2014 967.04M
March 31, 2014 835.09M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
argenx SE 1.160B
Evaxion AS --
Autolus Therapeutics Plc -224.98M
Pharma Mar SA 72.48M
Oryzon Genomics SA --